YU19002A - Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže - Google Patents

Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže

Info

Publication number
YU19002A
YU19002A YU19002A YUP19002A YU19002A YU 19002 A YU19002 A YU 19002A YU 19002 A YU19002 A YU 19002A YU P19002 A YUP19002 A YU P19002A YU 19002 A YU19002 A YU 19002A
Authority
YU
Yugoslavia
Prior art keywords
compositions
contain
preparation
piperidine derivatives
propyl piperidine
Prior art date
Application number
YU19002A
Other languages
English (en)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU19002A publication Critical patent/YU19002A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivati hinolil-propil-piperidina opste formule (I) u kojoj R1 oznacava H ili halogen, ili OH, R'1 je H, ili moze oznacavati halogen kada R1 takodje oznacava halogen, i R0 oznacava H, ili R1 i R0 zajedno formiraju vezu i R'1 oznacava H, R2 oznacava radikal karboksi, karboksimetil ili 2-karboksietil, i R3 oznacava alkil (1-6 C-atoma) koji je supstituisan sa 1-3 supstituenta odabrana izmedju OH, halogena, =O, COOH, alkiloksikarbonila, alkiloksi, alkiltio ili izmedju radikala fenila, feniltio ili fenilalkiltio koji sami mogu nositi 1-4 supstituenta [odabrana izmedju halogena, OH, alkila, alkiloksi, trifluormetila, trifluormetoksi, COOH, alkiloksikarbonila, CN, acetamido ili NH2] ili izmedju cikloalkila ili cikloalkiltio (3-7 clanova), ili izmedju aromaticnog heterociklila ili heterocikliltio (5-6 clanova) koji obuvhata 1-4 heteroatoma odabrana izmedju N, O ili S i koji su u datom slucaju sami supstituisani [halogenom, OH, alkilom, alkiloksi, CF3, OCF3, =OCOOH, alkiloksikarbonila, CN ili NH2], ili R3 oznacava propargil koji je supstituisan fenilom koji sam moze nositi 1-3 supstituenta [odabrana izmedju halogena, OH, alkila, alkiloksi, CF3, OCF3, COOH, alkiloksikarbonila, CN ili NH2], ili koji je supstituisan radikalom cikloalkilom koji sadrzi 3-7 clanova ili koji je supstituisan aromaticnim heterociklilom (5-6 clanova) koji obuhvata 1-4 heteroatoma odabrana izmedju N, O ili S i koji je u datom slucaju sam supstituisan [halogenom, OH, alkilo, alkiloksi, CF3, OCF3, =O, COOH, alkiloksikarbonilom, CN ili NH2], ili R3 oznacava cinamil ili 4-fenilbuten-3-il, ili R2 oznacava -CH2OH, alkiloksikarbonil, alkiloksikarbonil-metil ili alkiloksikarbonil-2-etil i R3 oznacava alkil (1-6 C-atoma) koji je supstituisan sa feniltio koji sam moze nositi 1-3 supstituenta [odabrana izmedju halogena, OH, alkila, alkiloksi, CF3, OCF3, COOH, alkiloksikarbonilom, CN ili NH2], sa cikloalkiltio (3-7 clanova) ili sa aromaticnim heterocikliltio (5-6 clanova) koji obuhvata 1-4 heteroatoma odabrana izmedju N, O ili S i koji je u datom slucaju sam supstituisan [halogenom, OH, alkilom, alkiloksi, CF3, OCF3, =O, COOH, alkiloksikarbonilom, CN ili NH2] ili R3 oznacava propargil koji je supstituisan fenilom koji sam moze nositi 1-3 supstituenta [odabrana izmedju halogena, OH, alkila, alkiloksi, CF3, OCF3, COOH, alkiloksikarbonila, CN ili NH2] ili koji je supstituisan cikloalkiom koji sadrzi 3-7 clanova ili koji je supstituisan aromaticnim heterociklilom sa 5-6 clanova koji obuhvata 1-4 heteroatoma odabrana izmedju N, O ili S i koji je u datom slucaju sam supstituisan [halogenom, OH, alkilom, alkiloksi, CF3, OCF3, =O, COOH, alkiloksikarbonilom, CN ili NH2], i R4 oznacava radikal alkil (1-6 C-atoma), alkenil-CH2- ili alkinil-CH2- (3-7 C-atoma), u obliku svojih diastereoizomera ili njihovih smesa, kao i u obliku svojih soli. Ovi novi derivati su narocito prikladni antimikrobni agensi.
YU19002A 1999-09-17 2000-09-14 Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže YU19002A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
YU19002A true YU19002A (sh) 2005-06-10

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
YU19002A YU19002A (sh) 1999-09-17 2000-09-14 Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže

Country Status (30)

Country Link
EP (2) EP1218370B1 (sh)
JP (1) JP2004527448A (sh)
KR (1) KR20020038757A (sh)
CN (1) CN1374959A (sh)
AP (1) AP2002002459A0 (sh)
AT (1) ATE284399T1 (sh)
AU (1) AU7429500A (sh)
BG (1) BG106524A (sh)
BR (1) BR0014060A (sh)
CA (1) CA2383836A1 (sh)
CZ (1) CZ2002940A3 (sh)
DE (2) DE60016611T2 (sh)
DZ (1) DZ3195A1 (sh)
EA (1) EA005183B1 (sh)
EE (1) EE200200138A (sh)
FR (1) FR2798656B1 (sh)
GE (1) GEP20043223B (sh)
HR (1) HRP20020214A2 (sh)
HU (1) HUP0204283A3 (sh)
IL (1) IL148720A0 (sh)
MA (1) MA26820A1 (sh)
MX (1) MXPA02001979A (sh)
NO (1) NO20021253L (sh)
OA (1) OA12022A (sh)
PL (1) PL354809A1 (sh)
SK (1) SK3632002A3 (sh)
TN (1) TNSN00184A1 (sh)
WO (1) WO2001025227A2 (sh)
YU (1) YU19002A (sh)
ZA (1) ZA200202073B (sh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
IL154107A0 (en) 2000-07-26 2003-07-31 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
WO2003064421A1 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
BR0315221A (pt) * 2002-10-10 2005-08-23 Morphochem Ag Komb Chemie Compostos com atividade antibacteriana
AU2003303956A1 (en) 2002-11-05 2004-11-23 Smithkline Beecham Corporation Antibacterial agents
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
WO2004050036A2 (en) 2002-12-04 2004-06-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EP1799674B1 (en) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. New piperidine antibiotics
CA2581057A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2007086016A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
JP5653935B2 (ja) 2009-01-15 2015-01-14 グラクソ グループ リミテッドGlaxo Group Limited 抗菌薬として有用なナフチリジン―2(1h)−オン化合物
EP3057948B1 (en) * 2013-10-14 2018-03-14 Eisai R&D Management Co., Ltd. Selectively substituted quinoline derivatives
EP3639824A1 (en) 2014-08-22 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
SG11201804170RA (en) 2015-12-17 2018-06-28 Merck Patent Gmbh Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
EP3497094B1 (en) 2016-08-08 2023-02-15 Merck Patent GmbH Tlr7/8 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051413B1 (en) * 1998-01-26 2003-06-04 SmithKline Beecham plc Quinoline derivatives as antibacterials
EP1144404A1 (en) * 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
CN1374959A (zh) 2002-10-16
MXPA02001979A (es) 2002-08-20
TNSN00184A1 (fr) 2005-11-10
HUP0204283A3 (en) 2004-07-28
GEP20043223B (en) 2004-04-26
EA200200374A1 (ru) 2002-10-31
JP2004527448A (ja) 2004-09-09
EP1218370A2 (fr) 2002-07-03
BG106524A (en) 2003-01-31
BR0014060A (pt) 2002-05-21
PL354809A1 (en) 2004-02-23
NO20021253L (no) 2002-04-24
HUP0204283A2 (hu) 2003-04-28
ZA200202073B (en) 2003-08-27
DE60034713T2 (de) 2008-01-17
SK3632002A3 (en) 2003-04-01
DE60034713D1 (de) 2007-06-14
DZ3195A1 (fr) 2001-04-12
NO20021253D0 (no) 2002-03-13
EP1484328A1 (fr) 2004-12-08
FR2798656A1 (fr) 2001-03-23
HRP20020214A2 (en) 2005-04-30
KR20020038757A (ko) 2002-05-23
DE60016611D1 (de) 2005-01-13
OA12022A (fr) 2006-04-19
EE200200138A (et) 2003-06-16
EP1218370B1 (fr) 2004-12-08
MA26820A1 (fr) 2004-12-20
CA2383836A1 (fr) 2001-04-12
CZ2002940A3 (cs) 2002-07-17
AU7429500A (en) 2001-05-10
IL148720A0 (en) 2002-09-12
EA005183B1 (ru) 2004-12-30
WO2001025227A2 (fr) 2001-04-12
DE60016611T2 (de) 2005-12-22
ATE284399T1 (de) 2004-12-15
WO2001025227A3 (fr) 2001-11-22
EP1484328B1 (fr) 2007-05-02
AP2002002459A0 (en) 2002-06-30
FR2798656B1 (fr) 2004-12-17

Similar Documents

Publication Publication Date Title
YU19002A (sh) Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK1200418T3 (da) Nematodicide trifluorbutener
BG106586A (en) Pyrazolopyramidines as therapeutic agents
TR200200409T2 (tr) Mantar öldürücü heterosiklik aromatik amitler ve bileşimleri, bunları kullanma ve hazırlama yöntemleri.
WO2002081448A1 (en) Benzamidine derivative
MX9700883A (es) Derivados sustituidos de la quinazolina.
IL145633A0 (en) Pharmaceutical compounds
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
AU4023093A (en) Novel substituted tertiary amino compound or salt thereof
AU4609701A (en) Colouring agent for keratin containing fibres
BG106235A (en) Streptogramin derivatives, preparation and compositions containing them
NZ515025A (en) Solvates of pymetrozine
AU3784597A (en) Fat emulsion containing xanthine derivative
AU1171897A (en) 1-methylcarbapenem derivatives
TW354762B (en) Agent for prophylaxis or treatment of cataract
IL135634A0 (en) 5-htif agonists
IL157440A0 (en) Triazole derivatives and pharmaceutical compositions containing the same
EP1121932A4 (en) MEDICINE FOR EYE DISEASES
ZA981430B (en) Anticancer composition
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
SE9704770D0 (sv) New use
GB9901253D0 (en) Bis-terpyridine-platinum(II) complexes
EP1067138A4 (en) HYDROXYPROLINE DERIVATIVES
AU2002214056A1 (en) Farnesyl transferase inhibiting benzoheterocyclic derivatives